NIRX MEDICAL TECHNOLOGIES LLC

NIRX MEDICAL TECHNOLOGIES LLC specializes in the design, development, and manufacturing of precision analytical laboratory instruments used in biomedical research and clinical diagnostics. Leveraging expertise in sensor integration, signal processing, and microfluidic systems, the company delivers high-performance instrumentation that supports quantitative analysis of biological samples, enabling accurate data acquisition for health research applications. Their technical focus includes calibration standards, low-noise detection architectures, and compliance with laboratory-grade reliability requirements, positioning them as a niche provider of mission-critical equipment for regulated scientific environments. The contractor has established a consistent relationship with the Department of Health and Human Services, supplying specialized analytical instruments that support public health surveillance, clinical validation studies, and laboratory infrastructure modernization. Their work aligns with HHS’s mission to advance biomedical research through reliable, reproducible data collection tools, suggesting a track record of delivering equipment that meets stringent federal quality and performance benchmarks. Operating under NAICS 334516, NIRX Medical Technologies focuses exclusively on analytical laboratory instrument manufacturing, a niche segment within the broader medical device industry. This specialization reflects a targeted market position serving research institutions, public health labs, and federal agencies requiring custom or high-precision instrumentation not readily available through commercial off-the-shelf solutions. As a small business structured as a 2K entity based in Glen Head, New York, NIRX Medical Technologies operates with agility and technical focus. While currently holding no formal government certifications, their consistent award history with HHS demonstrates proven capability to meet federal procurement standards and deliver mission-critical instrumentation within regulated environments. Their geographic presence in the New York metropolitan area supports proximity to key biomedical research hubs and federal laboratories.